Fluoxetine Enteric Tablet Versus Fluoxetine in Continuation Treatment of Major Depressive Disorder:A Multicentre Randomized Double-Blind Controlled Study

张鸿燕,姜荣环,舒良,李华芳,殷美莉,顾牛范,黄淑贞,卢苓,李占江,顾世芬,谢世平,李强,高成阁

DOI: https://doi.org/10.3760/j.issn:1006-7884.2007.01.004

2007-01-01

Abstract:Objective To evaluate the efficacy and safety of fluoxetine enteric tablet in the continuation treatment of major depressive disorder.Methods A randomized,double-blind,controlled multicentre clinical trial was conducted.All subjects(n=232)were randomized to receive either fluoxetine enteric tablet(n=116)or fluoxetine(n=116)for 12 weeks.The dosages were 90 mg weekly and 20 mg daily respectively.Results The fluoxetine enteric tablet showed equivalent therapeutic effect compared to fluoxetine.Only one patient in each group had symptom fluctuation.The relapse rate(0.9%)was same in both groups,and the stable rates were similar(90.4% vs.89.7%,P0.05).The total rates of adverse events were 20.9% and 20.7% in both groups(P0.05).The common adverse events included dry mouth,nausea,anxiety and somnolence.Conclusion The results show that fluoxetine enteric tablet have similar therapeutic effect and safety to fluoxetine in continuation treatment of major depressive disorder,with more convenient usage.